ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TRDA Entrada Therapeutics Inc

19.37
0.33 (1.73%)
27 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00025.26M18.17M43.74M41.85M59.12M
Operating Income -23.58M-25.94M-25.58M-5.78M-16.3M14.01M4.91M21.11M
Pre Tax Income -23.18M-25.14M-24.63M-3.12M-12.08M18.06M9.2M25.33M
Net Income -23.18M-25.14M-24.63M-6.67M-25.93M35.46M-9.54M23.5M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -23.58M-25.94M-25.58M-5.78M-16.3M14.01M4.91M21.11M
EBITDA -23.12M-25.42M-25.05M-5.24M-15.57M14.85M5.64M22.05M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 00129.01M
Operating Income -51.13M-97.25M-3.16M
Pre Tax Income -51.16M-94.62M12.06M
Net Income -51.16M-94.62M-6.69M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -1.638-3.014-0.2
EBIT -51.13M-97.25M-3.16M
EBITDA -50.03M-95.35M-321k